Κωνσταντίνος Κατσάνος

The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission

ECCO Guidelines on Inflammatory Bowel Disease and Malignancies

ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment

ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment

ECCO Topical Review Optimising Reporting in Surgery, Endoscopy, and Histopathology

ECCO Topical Review: Refractory Inflammatory Bowel Disease

Results of the Seventh Scientific Workshop of ECCO: Precision Medicine in IBD—What, Why, and How

Quality of Care Standards in Inflammatory Bowel Diseases: a European Crohn’s and Colitis Organisation [ECCO] Position Paper

Inflammatory Cutaneous Lesions in Inflammatory Bowel Disease Treated With Vedolizumab or Ustekinumab: An ECCO CONFER Multicentre Case Series

Aortic Stiffening Is an Extraintestinal Manifestation of Inflammatory Bowel Disease: Review of the Literature and Expert Panel Statement

The use of 5‐aminosalicylate for patients with Crohn’s disease in a prospective European inception cohort with 5 years follow‐up – an Epi‐IBD study

ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment

ECCO Guidelines on Therapeutics in Crohn’s Disease: Surgical Treatment

Perioperative Dietary Therapy in Inflammatory Bowel Disease

ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications

Management of Paediatric Ulcerative Colitis, Part 1

ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 2: IBD scores and general principles and technical aspects

Natural disease course of Crohn’s disease during the first 5 years after diagnosis in a European population-based inception cohort: an Epi-IBD study

Natural Disease Course of Ulcerative Colitis During the First Five Years of Follow-up in a European Population-based Inception Cohort—An Epi-IBD Study

Effectiveness and Safety of Vedolizumab in Anti-TNF-Naïve Patients With Inflammatory Bowel Disease—A Multicenter Retrospective European Study

Disease course of inflammatory bowel disease unclassified in a European population‐based inception cohort: An Epi‐IBD study

Vitamin D deficiency in a European inflammatory bowel disease inception cohort: an Epi-IBD study

Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management

European Crohn’s and Colitis Organisation Topical Review on Treatment Withdrawal [‘Exit Strategies’] in Inflammatory Bowel Disease

Predicting Outcomes to Optimize Disease Management in Inflammatory Bowel Diseases

Results of the Fifth Scientific Workshop of the ECCO [II]: Clinical Aspects of Perianal Fistulising Crohn’s Disease—the Unmet Needs

Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

European evidence based consensus for endoscopy in inflammatory bowel disease

Doubling the infliximab dose versus halving the infusion intervals in Crohnʼs disease patients with loss of response